跳轉至內容
Merck

Epidermal growth factor receptor in tumor angiogenesis.

Hematology/oncology clinics of North America (2004-10-12)
Lee M Ellis
摘要

This article focuses on the preclinical evidence for activation of the epidermal growth factor receptor (EGFR) in promoting angiogenesis and the efficacy of anti-EGFR agents in inhibiting angiogenesis and tumor growth.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
VEGF165, recombinant, expressed in HEK 293 cells, suitable for cell culture